KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBITDA: 2018-2025

Historic EBITDA for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$26.9 million.

  • Twist Bioscience's EBITDA rose 21.89% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.8 million, marking a year-over-year increase of 62.71%. This contributed to the annual value of -$77.8 million for FY2025, which is 62.70% up from last year.
  • As of Q3 2025, Twist Bioscience's EBITDA stood at -$26.9 million, which was down 233.25% from $20.2 million recorded in Q2 2025.
  • Twist Bioscience's 5-year EBITDA high stood at $20.2 million for Q2 2025, and its period low was -$85.6 million during Q2 2024.
  • Moreover, its 3-year median value for EBITDA was -$42.8 million (2023), whereas its average is -$40.8 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 68.78% in 2021, then skyrocketed by 123.57% in 2025.
  • Over the past 5 years, Twist Bioscience's EBITDA (Quarterly) stood at -$45.4 million in 2021, then grew by 5.12% to -$43.1 million in 2022, then climbed by 0.56% to -$42.8 million in 2023, then increased by 25.91% to -$31.7 million in 2024, then rose by 21.89% to -$26.9 million in 2025.
  • Its EBITDA stands at -$26.9 million for Q3 2025, versus $20.2 million for Q2 2025 and -$39.3 million for Q1 2025.